Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Antistaphylococcal Penicillins and Cefazolin on the Emergence of Resistance in French Hospitals

NCT05939479 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT05939479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Antistaphylococcal Penicillins and Cefazolin on the Emergence of Resistance in French Hospitals
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
June 1, 2023
Enrollment
644 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial resistance, methicillin-sensitive staphylococcus aureus infection